Many groups recommend assessment of patient preferences particularly for patients with advanced, incurable cancer. We, therefore, developed the Patient Preference Assessment Tool (PPAT) to ascertain patient preferences in order to inform clinician recommendations and improve shared decision-making. The aim of this study is to assess the PPAT's impact on clinicians' strength of recommendations for phase I oncology clinical trials.

中文翻译：

---

评估患者偏好评估工具对临床医生对 I 期肿瘤学临床试验的建议的影响

许多团体建议评估患者的偏好，特别是对于晚期、无法治愈的癌症患者。因此，我们开发了患者偏好评估工具 (PPAT) 来确定患者偏好，以便为临床医生提供建议并改进共同决策。本研究的目的是评估 PPAT 对临床医生对 I 期肿瘤临床试验推荐强度的影响。